FCA regulated investment advisory house that focuses on early-stage technology SMEs in healthcare, sustainability, and software.
Portfolio
2
companies
Reacta Biotech
Produces standardised diagnostic kits for clinical food allergy testing.
Vertical Future
Vertical Future builds controlled environment agriculture systems for scalable indoor crop production.
Simon Thorn
Managing Director
Patrick Molyneux
Corporate Finance Director
Patrick brings corporate finance and venture advisory experience from roles at KPMG and Acceleris Capital, alongside committee membership at the Enterprise Investment Scheme Association.
LinkedInThe funding round was backed by Moulton Goodies, Development Bank of Wales, and Acceleris.
"This investment is a significant step in the development of Reacta Biotech’s business. A combination of seeking our own MHRA approval and the recent FDA approval of the first specific food allergy therapy set to launch in the US soon, creates ideal timing for Reacta to become the only standardised and trusted OFC for all food allergy therapeutics."
The London-based food technology company has raised £4m from Earthworm and other backers to build new plant factories and scale production.
"Following several years of hard work, today's raise validates our growth strategy and strong position in the London market, furthering our mission to improve the food and health of urban inhabitants, starting in London"
